Woodbridge, CT, United States of America

Leonard Bell

USPTO Granted Patents = 14 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 17)

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 143(Granted Patents)

Company Filing History:

10 out of 196

Alexion Pharmaceuticals, Inc.

Oklahoma Medical Research Foundation

patents

where one patent can have more than one assignee

Years Active: 1994-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11244744 - Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor (2022-02-08),

2. 11031102 - Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor (2021-06-08),

3. 10703809 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement (2020-07-07),

4. 10590189 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement (2020-03-17),

5. 9771418 - Methods for treating complement-associated disorders (2017-09-26),

6. 9732149 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement (2017-08-15),

7. 9725504 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement (2017-08-08),

8. 9718880 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement (2017-08-01),

9. 9447176 - Methods and compositions for treating complement-associated disorders (2016-09-20),

10. 7361339 - Methods for reducing morality associated with acute myocardial infarction (2008-04-22),

11. 6916654 - Universal donor cells (2005-07-12),

12. 6100443 - Universal donor cells (2000-08-08),

13. 5705732 - Universal donor cells (1998-01-06),

14. 5336615 - Genetically engineered endothelial cells exhibiting enhanced migration (1994-08-09),

Title: The Innovative Journey of Leonard Bell

Introduction

Leonard Bell, a distinguished inventor based in Woodbridge, CT, has made significant contributions to the field of medicine and healthcare through his innovative inventions. Holding a total of 14 patents, he is recognized for his work in developing advanced treatment plans and risk management strategies focusing on patient care.

Latest Patents

One of Leonard Bell's latest patents revolves around a risk evaluation and management strategy (REMS) involving patient follow-ups related to the use or discontinuation of a complement inhibitor. This groundbreaking invention provides a comprehensive treatment plan that integrates REMS and a safety support program (SSP). These programs are implemented using computer devices equipped with software tools designed to enforce REMS conditions and prompt follow-ups by registered nurses. The tools also assess whether a prescriber agrees to follow REMS guidelines and ensure that updated educational materials are provided to them periodically. This innovative approach aims to manage the risk of adverse events, particularly meningococcal infections, thereby enhancing patient safety and reducing the incidence of such events.

Career Highlights

Leonard's career has been marked by collaborations with eminent companies and institutions in the pharmaceutical and healthcare sectors. Notably, he has worked with Alexion Pharmaceuticals, Inc., where his innovations have contributed to advancing healthcare solutions. Furthermore, his association with Yale University has helped bridge the gap between academic research and practical applications in medicine.

Collaborations

Throughout his professional journey, Leonard has collaborated with notable colleagues, including Russell P. Rother and Mark James Evans. These collaborations have fostered a fruitful exchange of ideas and expertise, further enriching Leonard's contributions to the field of healthcare innovation.

Conclusion

Leonard Bell's inventive spirit and dedication to healthcare innovation continue to shape the landscape of medical treatments. With his significant patent portfolio and valuable collaborations, he remains a key figure in advancing strategies that prioritize patient safety and effective healthcare management.

This text is generated by artificial intelligence and may not be accurate.